Perbedaan Prodia Diagnostic Line Tbk dan Zyrexindo Mandiri Buana Tbk.: Prodia Diagnostic Line Tbk diperdagangkan di Rp260 (kapitalisasi pasar 470,58 M, volume 24 jam 7,44 jt), sedangkan Zyrexindo Mandiri Buana Tbk. diperdagangkan di Rp130 (kapitalisasi pasar 178,67 M, volume 24 jam 353,4 rb). Perbedaan utamanya: Prodia Diagnostic Line Tbk jauh lebih besar — sekitar 2,6× kapitalisasi pasar Zyrexindo Mandiri Buana Tbk., dan Prodia Diagnostic Line Tbk lebih aktif diperdagangkan (7,44 jt vs 353,4 rb). Mana yang lebih baik tergantung tujuan investasimu.
| PRDL | ZYRX | |
|---|---|---|
Kapitalisasi Pasar | 470,58 M | 178,67 M |
Volume | 7,44 jt | 353,4 rb |
Lot | 74,43 rb | 3,53 rb |
Perputaran | 1,96 M | 45,77 jt |
Harga Rata-rata | 263,39 | 129,52 |
Nilai Transaksi | 1,96 M | 45,77 jt |
Harga Ekuilibrium Indikatif | 272 | 134 |
Volume Ekuilibrium Indikatif | 418 | 1,5 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Selengkapnya di halaman PRDL →PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik
Selengkapnya di halaman ZYRX →